ImmunityBio Q1 Earnings Preview: I Fear A Selloff, But Am Long-Term Bullish
If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.I have covered ImmunityBio, Inc. (NASDAQ: IBRX ) in several posts for Seeking Alpha, beginning in April last year , issuing a “Hold” rating, then following up in August and ...